- Robert Koch Prize (1975)
- Charles S. Mott Prize (1986)
- Paul-Ehrlich-und-Ludwig-Darmstaedter-Preis (1994)
- Virchow Medal from the University of Würzburg (2000)
- San Marino Prize for Medicine (2002)
- Great Cross of Merit (2004)
- German Cancer Aid Award (2006)
- William B. Coley Award for Distinguished Research in Basic and Tumor Immunology in 2006 (with Ian Frazer)
- Gairdner Foundation International Award (2008)
- Nobel Prize in Physiology or Medicine (2008)
- Honorary degrees of the universities of Chicago, Umeå, Prague, Salford, Helsinki, Erlangen-Nuremberg and Salerno
1. H. zur Hausen : Induction of specific chromosomal aberrations by adenovirus type 12 in human embryonic kidney cells. J. Virol. 1, 1174-1185, 1967
2. H. zur Hausen : Association of adenovirus type 12 deoxyribonucleic acid with host cell chromosomes. J. Virol. 2, 218-223, 1968
3. H. zur Hausen : Chromosomal aberrations and cloning efficiency in adenovirus type 12-infected hamster cells. J. Virol. 2, 915-917, 1968
4. H. zur Hausen : Persistence of the virus genome in adenovirus type 12-infected hamster cells. J. Virol. 2, 918-924, 1968
5. B.B. Knowless, H. zur Hausen, Z. Steplewski, and H. Koprowski : Interactions of tumor viruses following fusion of transformed cells. Genetics 60, 194, 1968
6. H. zur Hausen : Failure to detect incorporation of host cell DNA into virions of adenovirus type 12. Virology 38, 194-197, 1969
7. H. zur Hausen and F. Sokol : The fate of adenovirus type 12 genome in nonpermissive cells. J. Virol. 4, 256-263, 1968
8. H. zur Hausen : Interactions of adenovirus type 12 with host cell chromosomes. In: Oncogenic Adenoviruses, Progr. Exptl. Tumor Res., S. Karger, Basel-New York, 18, 240-259, 1973
9. G. Werner and H. zur Hausen: Deletions and insertions in adenovirus type 12 DNA after viral replication in Vero cells. Virology 86, 66-78, 1978
10. I. Kruczek, E. Schwarz, and H. zur Hausen: Mutants of adenovirus type 12 after adaptation to growth in tumor cell lines: II. Reproducible acquisition of sequences after adaptation to a human cervical cancer cell line. Int. J. Cancer 27, 139-143, 1981
11. E. Schwarz, C. Reinke, N. Yamamoto, and H. zur Hausen: Terminal rearrangements in the genome of adenovirus type 12 mutants adapted to growth in two human tumor cell lines. Virology 116, 284-296, 1982
12. J.R. Schlehofer and H. zur Hausen: Adenovirus infection induces amplification of persistent viral DNA sequences (simian virus 40, hepatitis B virus, bovine papillomavirus) in human and rodent cells. Virus Res. 17, 53-60, 1990
13. T. Rothmann, A. Hengstermann, N.J. Whitaker, M. Scheffner, and H. zur Hausen: Replication of ONYX-015, a potential anticancer adenovirus, is independent of the p53 status in tumor cells. J. Virol., 72, 9470-9478, 1998
14. Báez-Astúa, A., García Garbi, N., Pasolli, H.A., Herraez-Hernandez, E., Juarez, V., zur Hausen, H., and Cid-Arregui, A. Low-does adenoviral vaccine encoding chimeric HBsAg-HPV16 E7 proteins induces E7-specific antibody and cytotoxic T cell responses. J. Virol. 79: 12897-12817, 2005.
15. H. zur Hausen, W. Henle, K. Hummler, V. Diehl, and G. Henle : Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography and electronmicroscopy. J. Virol. 1, 830-837, 1967
16. W. Henle, V. Diehl, G. Kohn, H. zur Hausen, and G. Henle: Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157, 1064-1065, 1967
17. R. Waubke, H. zur Hausen and W. Henle : Chromosomal and autoradiographic studies of cells infected with Herpes simplex virus. J. Virol. 2, 1047-1054, 1968
18. W. Henle, G. Henle and H. zur Hausen : Effect of Herpes simplex virus in cultured Burkitt tumor cells and its failure to influence the EBV carrier state. Cancer Res. 29, 4489-494, 1969
19. H. Schulte-Holthausen and H. zur Hausen : Partial purification of the Epstein-Barr virus and some properties of its DNA.. Virology 40, 776-779, 1970
20. H. zur Hausen and H. Schulte-Holthausen : Presence of EB virus nucleic acid homology in a ”virus-free” line of Burkitt tumor cells. Nature (London) 227, 245-248, 1970
21. H. zur Hausen, H. Schulte-Holthausen, G. Klein, W. Henle, G. Henle, P. Clifford, and L Santesson : EBV DNA in biopsies of Burkitt tumours and anaplastic carcinoma of the nasopharynx. Nature (London) 228, 1056-1058, 1970
22. H. zur Hausen : Epstein-Barr virus in human tumor cells. Intern. Rev. Exptl. Path. 11, 233-258, 1972
23. H. zur Hausen, V. Diehl, H. Wolf, H. Schulte-Holthausen, and U. Schneider : Occurrence of EB virus genomes in human lymphoblastoid cell lines. Nature (London) 237, 189-190, 1972
24. V. Diehl, H. Wolf, H. Schulte-Holthausen, and H. zur Hausen: Re-exposure of human
lymphoblastoid cell lines to Epstein-Barr virus. Int. J. Cancer 10, 641-651, 1972
25. H. Wolf, H. zur Hausen and V. Becker : EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature (London) 244, 245-247, 1973
26. H. zur Hausen, H. Schulte-Holthausen, H. Wolf, K. Dörries, and H. Egger : Attempts to detect
virus-specific DNA in human tumors: II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses. Int. J. Cancer 13, 657-664, 1974
27. G. Klein, F. Wiener, L. Zech, H. zur Hausen, and B. Reedman: Segregation of EBV-determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of mouse fibroblasts. Int. J. Cancer 14, 54-64, 1974
28. H. Wolf, H. zur Hausen, G.Klein, V. Becker, G. Henle, and W. Henle: Attempts to detect virusspecific DNA sequences in human tumors: III. Epstein-Barr viral DNA in non-lymphoid
nasopharyngeal carcinoma cells. Med. Microbiol. Immunol. 161, 15-21, 1975
29. H. zur Hausen: Oncogenic Herpesviruses. Biochim. Biophys. Acta 417, 25-53, 1975
16. U. Schneider and H. zur Hausen: Epstein-Barr virus-induced transformation of human leukocytesafter cell fractionation. Int. J. Cancer 15, 59-66, 1975
30. M.A. Epstein, H. zur Hausen, G. Ball, and H. Rabin: Pilot experiments with EB virus in owl
monkeys (Aotus trivirgatus). III. Serological and biochemical findings in an animal with
reticuloproliferative disease. Int. J. Cancer 15, 17-22, 1975
31. J. Werner, H. Wolf, J. Apodoca, and H. zur Hausen: Lymphoproliferative disease in a cottontop marmoset after inoculation with infectious mononucleosis-derived Epstein-Barr virus. Int. J. Cancer 15, 1000-1008, 1975
32. C. Desgranges, H. Wolf, G. de Thé, K. Shanmugaratnam, N. Cammoun, R. Ellouz. G. Klein, K. Lennert, N. Munoz, and H. zur Hausen: Nasopharyngeal carcinoma. X. Presence of Epstein-Barr genomes in separated epithelial cells of tumors from Singapore, Tunesia and Kenya. Int. J. Cancer 16, 7-15, 1975
33. H. zur Hausen: DNA viruses in human cancer: biochemical approaches. Cancer Res. 36, 414-416,1976
34. G. Bornkamm, H. Stein, H. Bartels, F. Rüggeberg, K. Lennert, and H. zur Hausen: Attempts to detect virus-specific DNA sequences in human tumors: IV. EBV DNA in European Burkitt’s lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis. Int. J. Cancer 17, 177-181, 1976
35. K.O. Fresen and H. zur Hausen: Establishment of EBNA-expressing cell lines by infection of
Epstein-Barr virus (EBV) genome-negative human lymphoma cells with different EBV strains. Int. J. Cancer 17, 161-166. 1976
36. K.O. Fresen, B. Merkt, G.W. Bornkamm, and H. zur Hausen: Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction. Int. J. Cancer 19, 317-323, 1977
37. K.O. Fresen and H. zur Hausen: Transient induction of a nuclear antigen unrelated to EBNA in EBV-converted human B-lymphoma cells. Proc. Nat. Acad. Sci. U.S. 74, 363-366, 1977
38. H. zur Hausen and K.O. Fresen: Heterogeneity of Epstein-Barr virus. II. Induction of early
antigens (EA) by complementation. Virology 81, 138-143, 1977
39. zur Hausen, F.J. O’Neill, U. Freese, and E. Hecker: Persisting oncogenic herpesvirus induced
by the tumor promoter TPA. Nature 272, 373-375, 1978
40. K.O. Fresen, M.S. Cho, and H. zur Hausen: Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells. Int. J. Cancer 22, 160-165, 1978
41. K.O. Fresen, M.S. Cho, and H. zur Hausen: Recovery of transforming EBV from nonproducer
cells after superinfection with nontransforming P3HR-1 EBV. Int. J.Cancer 22, 378-383, 1978
42. H. zur Hausen and K.O. Fresen: Heterogeneity of Epstein-Barr virus. Biochim. Biophys. Acta, Reviews an Cancer 560, 343-353, 1979
43. H. zur Hausen, G.W. Bornkamm, R. Schmidt, and E. Hecker: Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc. Nat. Acad. Sci. U.S. 76, 782-785, 1979
44. K. Bister, N. Yamamoto, and H. zur Hausen: Correlation between genome number and inducibility of Epstein-Barr virus in nonproducer cells. Int. J. Cancer 23, 818-825, 1979
45. N. Yamamoto, K. Bister, and H. zur Hausen: Retinoic acid inhibition of Epstein-Barr virus
production. Nature 278, 553-554, 1979
46. K.O. Fresen, M.S. Cho, L. Gissmann, and H. zur Hausen: NC37-R1 EB virus: a possible
recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV. Intervirology 12, 303-310, 1979
47. N. Müller-Lantzsch, N. Yamamoto, and H. zur Hausen: Analysis of early and late induced EBV polypeptides. Virology 97, 378-387, 1979
48. N. Yamamoto and H. zur Hausen: Tumor promoter TPA enhances transformation of human
leukocytes by Epstein-Barr virus. Nature 280, 244-245, 1979
49. J. Hudewentz, G.W. Bornkamm, and H. zur Hausen: Effect of the diterpene ester TPA on Epstein-Barr virus DNA synthesis in producer and nonproducer cell lines. Virology 100, 175-178, 1980
50. N. Yamamoto and H. zur Hausen: Effect of inhibition of DNA synthesis on Epstein-Barr virus induction of tumor promoters. Virology 101, 104-110, 1980
51. F. Böcker, K.H. Tiedemann, G.W. Bornkamm, and H. zur Hausen: Characterization of an EBVlike virus from African green monkey lymphoblasts. Virology 101, 291-295, 1980
52. N. Müller-Lantzsch, B. Georg, N. Yamamoto, and H. zur Hausen: Epstein-Barr virus induced
proteins: II. Analysis of surface polypeptides from P3HR-1 superinfected NC37 cells by
immunoprecipitation. Virology 102, 401-411, 1980
53. N. Müller-Lantzsch, B. Georg, Y. Yamamoto, and H. zur Hausen: Epstein-Barr virus induced
proteins. III. Analysis of polypeptides from P3HR-1 superinfected NC37 cells by immunoprecipitation. Virology 102, 291-295, 1980
54. N. Yamamoto, N. Müller-Lantzsch, and H. zur Hausen: Effect of actinomycin D and
cycloheximide on Epstein-Barr virus induction in lymphoblastoid cells. J. Gen. Virol. 51, 255-261, 1980
55. N. Yamamoto, N. Müller-Lantzsch, and H. zur Hausen: Differential inhibition of Epstein-Barr
virus induction by the amino acid analogue, L-canavanine. Int. J. Cancer 25, 439-443, 1980
56. M.S. Cho, K.O. Fresen, and H. zur Hausen: Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV. Int. J. Cancer 26, 357-363, 1980
57. N. Müller-Lantzsch, B. Georg-Fries, H. Herbst, H. zur Hausen , and D. Braun: Epstein-Barr strain and group specific antigenic determinants detected by monoclonal antibodies. Int. J. Cancer 28,321-327, 1981
58. N. Yamamoto and H. zur Hausen: Induction of Epstein-Barr virus early antigens by intercalating chemicals in B95-8 cells. Virology 115, 390-394, 1981
59. G. Bauer, P. Höfler, and H. zur Hausen: Epstein-Barr virus induction by a serum factor. I.
Induction and cooperation with additional inducers. Virology 121, 184-194, 1982
60. J.R. Schlehofer and H. zur Hausen: Induction of mutations within the host cell genome by partially inactivated herpes simplex virus type 1. Virology 122, 471-475, 1982
61. H. zur Hausen: Human genital cancer – synergism between two virus infections or synergism
between a virus infection and initiating events. Lancet 2, 1370-1373, 1982
62. J.R. Schlehofer, L. Gissmann, B. Matz, and H. zur Hausen: Herpes simplex virus induced
amplification of SV40 sequences in transformed Chinese hamster cells. Int. J. Cancer 32, 99-103,1983
63. M. von Knebel Doeberitz, G.W. Bornkamm, and H. zur Hausen: Establishment of spontaneously outgrowing lymphoblastoid cell lines with cyclosporin A. Med. Microbiol. Immunol. 172, 87-99, 1983
64. H. zur Hausen: Herpes simplex virus in human genital cancer. Int. Rev. Exptl. Path. 25, 307-326,1983
65. B. Matz, J.R. Schlehofer, and H. zur Hausen: Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells. Virology 134, 328-337, 1984
66. L.W. Daniel, G. Bauer, and H. zur Hausen: Effect of indomethacin on Epstein-Barr virus early
antigen induction. Cancer Res. 44, 981-983, 1984
67. Takada and H. zur Hausen: Induction of Epstein-Barr virus antigens by tumor promoters for
epidermal and nonepidermal tissues. Int. J. Cancer 33, 491-496, 1984
68. M.S. Cho, G.W. Bornkamm, and H. zur Hausen: Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells. J. Virol. 51, 199-207, 1984
69. J. Skare, J. Farley, J.L. Strominger, K.O. Fresen, M.S. Cho, and H. zur Hausen: Transformation by Epstein-Barr virus requires DNA sequences in the region of Bam H1 fragments Y and H. J. Virol.55, 286-297, 1985
70. B. Matz, J.R. Schlehofer, H. zur Hausen, B. Huber, and F. Fanning: HSV- and chemical
carcinogenesis-induced amplification of SV40 DNA sequences in transformed cells is cell-line dependent. Int. J.Cancer 35, 521-525, 1985
71. J.R. Schlehofer, M. Ehrbar, and H. zur Hausen: Vaccinia virus, herpes simplex virus and
carcinogens induce DNA amplification in a human cell line and support replication of a helperdependent parvovirus. Virology 152, 110-117, 1986
72. R. Heilbronn, G. Jahn, A. Bürkle, U.-K. Freese, B. Fleckenstein, and H. zur Hausen: Genomic
localization, sequence analysis, and transcription of the human cytomegalovirus-induced DNA polymerase. J. Virol. 61, 119-124, 1987
73. zur Hausen and J.R. Schlehofer: The role of DNA amplification in tumor development:
Prospects from virological studies. In: Accomplishments in Oncology, H. zur Hausen and J.R.
Schlehofer, eds. Lippincott Co., Philadelphia, pp. 1-8, 1987
74. U. Bantel-Schaal and H. zur Hausen: Adeno-associated viruses inhibit SV 40 DNA amplificationand replication of herpes simplex virus in SV 40-transformed hamster cells. Virology 164, 64-74,1988
75. J. Schmitt, K. Mergener, L. Gissmann, J.R. Schlehofer, and H. zur Hausen: Amplification of
bovine papillomavirus DNA by N-methyl-N’-nitro-N-nitrosoguanidine, UV-irradiation, or infection by herpes simplex virus. Virology 172, 73-81, 1989
76. R. Heilbronn and H. zur Hausen: A subset of herpes simplex virus replication genes induces
amplification within the host cell genome. J. Virol. 63, 3683-3692, 1989
77. Wolf, M. Pawlita, J. Bullerdiek, and H. zur Hausen: Suppression of the malignant phenotype in somatic cell hybrids between Burkitt’s lymphoma cells and EBV-immortalized lymphoblastoid cells despite deregulated c-myc expression. Cancer Res. 50, 3095-3100, 1990
78. R. Heilbronn, S. Weller, and H. zur Hausen: Herpes simplex virus type 1 mutants for origin
binding protein induce DNA amplification in the absence of viral replication. Virology 179, 478-481,1990
79. R. Heilbronn, A. Bürkle, S. Stephan, and H. zur Hausen: The adeno-associated rep-gene
suppresses herpes simplex virus induced DNA amplification. J. Virol. 64, 3012-3018, 1990
80. J. Wolf, B. Klevenz, M. Pawlita, D. Komitowski, G. Moldenhauer, and H. zur Hausen: Regressing nude mouse grafts of Burkitt’s lymphoma x lymphoblastoid cell hybrids show deregulation of the cmycgene and expression of the EBV latent membrane protein. Int. J. Cancer 47, 99-104, 1991
81. J. Wolf, M. Pawlita, B. Klevenz, B. Frech, U.-K. Freese, N. Müller-Lantzsch, V. Diehl, and H. zurHausen: Downregulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt’slymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. Int. J. Cancer 53, 621-627, 1993
82. R. Heilbronn, I. Albrecht, S. Stephan, A. Bürkle, and H. zur Hausen: Human cytomegalovirus
induces JC virus replication in human fibroblasts. Proc. Nat. Acad. Sci. U.S. 90, 11406-11410, 1993
83. H. zur Hausen. Infections Causing Human Cancer. Wiley-VCH, Weinheim/New York (Publ.), pp.1-517, 2006.
Publications Papillomaviruses:
84. H. zur Hausen, W. Meinhof, W. Scheiber, and G.W. Bornkamm : Attempts to detect virus-specific DNA sequences in human tumors : I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int. J. Cancer 13, 650-656, 1974
85. H. zur Hausen, L. Gissmann, W. Steiner, W. Dippold, and J. Dregger: Human papilloma virusesand cancer. Bibliotheca Haematologica, J. Clemensen and D.S. Yohn (eds.) 43, 569-571, 1975
86. H. zur Hausen: Condylomata acuminata and human genital cancer. Cancer Res. 36, 530, 1976
87. L. Gissmann and H. zur Hausen: Human papilloma viruses: physical mapping and genetic
heterogeneity. Proc. Nat. Acad. Sci. U.S. 73, 1310-1313, 1976
88. L. Gissmann, H. Pfister, and H. zur Hausen: Human papilloma viruses (HPV): Characterization of four different isolates. Virology 76, 569-580. 1977
89. H. zur Hausen: Human papilloma viruses and their possible role in squamous cell carcinomas.
Current Topics in Microbiol. Immunol. 78, 1-30, 1977
90. H. Pfister, L. Gissmann, and H. zur Hausen: Partial characterization of the proteins of human
papilloma viruses (HPV) 1-3. Virology 83, 131-137, 1977
91. L. Gissmann and H. zur Hausen: Inverted repetitive sequences in human papilloma virus (HPV) DNA. Virology 83, 271-276, 1977
92. zur Hausen, L. Gissmann, H. Pfister, W. Steiner, and S. Ojwang: Papilloma viruses and
squamous cell carcinomas in man. Perspectives in Virology, M. Pollard (ed.), 10, 93-101, 1977
93. zur Hausen: Cell-virus gene balance hypothesis of carcinogenesis. Behring Inst. Mitt. 61,
23-30, 1977
94. H. Pfister and H. zur Hausen: Seroepidemiological studies of human papilloma virus (HPV-1)
infections. Int. J. Cancer 21, 161-165, 1978
95. L. Gissmann and H. zur Hausen: Physical characterization of different human papilloma viruses. Med. Microbiol. Immunol. 166, 3-11, 1978
96. H. Pfister and H. zur Hausen: Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1. Med. Microbiol. Immunol. 166, 13-19, 1978
97. H. Pfister, B. Huchthausen, G. Gross, and H. zur Hausen: Seroepidemiological studies of bovine papilloma virus infections. J. Natl. Cancer Inst. 62, 1423-1425, 1979
98. H. Pfister, U. Linz, L. Gissmann, B. Huchthausen, D. Hofmann, and H. zur Hausen: Partial
characterization of a new type of bovine papillomaviruses. Virology, 96, 1-8, 1979.
99. E.I. Grussendorf and H. zur Hausen: Localization of viral DNA replication in sections of human warts by nucleic acid hybridization with complementary RNA of human papilloma virus type 1. Arch. Derm Res. 264, 55-63, 1979
100. J.R. Coggins jr. and H. zur Hausen: Workshop on papillomaviruses and cancer. Cancer Res. 39, 545-546, 1979
101. L. Gissmann and H. zur Hausen: Partial characterization of viral DNA from human genital warts (condylomata acuminata). Int. J. Cancer 25, 605-609, 1980
102. H. Pfister, F. Nürnberger, L. Gissmann, and H. zur Hausen: Characterization of a human
papillomavirus from Epidermodysplasia verruciformis lesions of a patient from Upper Volta. Int. J. Cancer 27, 645-650, 1981
103. H. zur Hausen, E.-M. de Villiers, and L. Gissmann: Papillomavirus infections and human genital cancer. J. Gyn. Oncol. 12, 124-128, 1981
104. E.-M. de Villiers, L. Gissmann, and H. zur Hausen: Molecular cloning of viral DNA from human genital warts. J. Virol. 40, 932-935, 1981
105. L. Gissmann, E.-M. de Villiers, and H. zur Hausen: Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int. J. Cancer 29,143-146, 1982
106. Gissmann, V. Diehl, H. Schultz-Coulon, and H. zur Hausen: Molecular cloning and
characterization of human papillomavirus DNA from a laryngeal papilloma. J. Virol. 44, 393-400,1982
107. L. Gissmann, L. Wolnik, H. Ikenberg, U. Koldovsky, H.G. Schnürch, and H. zur Hausen: Human papillomavirus type 6 and 11 sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Nat. Acad. Sci. U.S. 80, 560-563, 1983
108. M. Dürst, L. Gissmann, H. Ikenberg, and H. zur Hausen: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Nat. Acad. Sci. U.S. 80, 3812-3815, 1983
109. H. Ikenberg, L. Gissmann, G. Gross, E.-I. Grussendorf-Conen, and H. zur Hausen: Human
papillomavirus type 16 related DNA in genital Bowen’s disease and in Bowenoid papulosis. Int. J.Cancer 32, 563-564, 1983
110. E. Schwarz, M. Dürst, C. Demankowski, O. Lattermann, R. Zech, E. Wolfsberger, S. Suhai, and H.zur Hausen: DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J. 2, 2341-2348, 1983
111. M. Boshart, L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, and H. zur Hausen: A new type of papillomavirus DNA, its presence in genital cancer and in cell lines derived from genital cancer. EMBO J. 3, 1151-1157, 1984.
112. L. Gissmann, M. Boshart, M. Dürst, H. Ikenberg, D. Wagner, and H. zur Hausen: Presence of
human papillomavirus in genital tumors. J. Invest. Dermatol. 83, 26-28, 1984
113. A. Stremlau, L. Gissmann, H. Ikenberg, E. Stark, and H. zur Hausen: Human papillomvirus type 16 DNA in an anaplastic carcinoma of the lung. Cancer 55, 1737-1740, 1985
114. E. Schwarz, U.K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, and H. zur Hausen: Structure and transcription of human papillomavirus type 18 and 16 sequences in cervical carcinoma cells. Nature 314, 111-114, 1985
115. T. Löning, H. Ikenberg, J. Becker, L. Gissmann, I. Hoepfner, and H. zur Hausen:
Analysis of oral papillomas, leukoplakias and invasive carcinomas for human papillomavirus type related DNA. J. Invest. Dermatol. 84, 417-420, 1985
116. H. Ikenberg, D. Neumann-Haefelin, B. Richthammer, W. Wolfahrt, C.P. Adler, G. Bodo, L.
Gissmann, and H. zur Hausen: Interferon therapy for bronchial papillomatosis controlled by
papillomavirus DNA hybridization. Arch. Otolaryngol. 111, 96-98, 1985
117. E.-M. de Villiers, H. Weidauer, H. Otto, and H. zur Hausen: Papillomavirus DNA in human
tongue carcinomas. Int. J. Cancer 36, 575-578, 1985
118. K. Dartmann, E. Schwarz, L. Gissmann, and H. zur Hausen: The nucleotide sequence and genome organization of human papillomvirus type 11. Virology 151, 124-130, 1986
119. E.-M. de Villiers, A. Schneider, G. Gross, and H. zur Hausen: Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA Med. Microbiol. Immunol. 174, 281-286, 1986
120. E.-M. de Villiers, C. Neumann, J.Y. Le, H. Weidauer, and H. zur Hausen: Infection of the oral
mucosa with defined types of human papillomaviruses. Med. Microbiol. Immunol. 174, 287-294, 1986
121. M. de Villiers, T. Oltersdorf, C. Neumann, G. Fierlbeck, and H. zur Hausen: Butcher’s wart
virus (HPV7) infections in non-butchers. J. Invest. Dermatol. 87, 236-238, 1986
122. Y. Tsunokawa, N. Takebe, S. Nozawa, T. Kasamatsu, L. Gissmann, H. zur Hausen, M. Terada, and T. Sugimura: Presence of human papillomavirus type 16 and 18 sequences and their expression in cervical cancers and cell lines from Japanese patients. Int. J. Cancer 37, 499-503, 1986
123. T. Kahn, E. Schwarz, and H. zur Hausen: Molecular cloning and characterization of the DNA of a new human papillomavirus (HPV 30) from a laryngeal carcinoma. Int. J. Cancer 37, 61-65, 1986
124. E. Schwarz, A. Schneider-Gaedecke, B. Roggenbuck, W. Mayer, L. Gissmann, and H. zur Hausen: Expression of human papillomavirus DNA in cervical carcinoma cell lines. Banburry Report 21: Viral Etiology of Cervical Cancer (R. Peto and H. zur Hausen, eds.) pp. 281-290, 1986
125. W. Scheurlen, A. Stremlau, L. Gissmann, D. Höhn, H.-P. Zenner, and H. zur Hausen: Rearranged HPV 16 molecules in an anal carcinoma and in a larygeal carcinoma. Int. J. Cancer 38, 671-676, 1986
126. Scheurlen, L. Gissmann, G. Gross, and H. zur Hausen: Molecular cloning of two new HPV
types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int. J.Cancer 37, 505-510, 1986
127. H. zur Hausen: Evidence for an association between human papillomaviruses and neoplasia. Int.Med. for the Specialist 7, 66-79, 1986
128. E.-M. de Villiers, H. Weidauer, J.-Y. Le, C. Neumann, and H. zur Hausen: Papillomaviren inbenignen und malignen Tumoren des oberen Respirationstraktes. Laryng. Rhinol. Otol. 65, 177-179, 1986
129. M. Boshart and H. zur Hausen: Human papillomaviruses (HPV) in Buschke-Loewenstein tumors:physical state and identification of a tandem duplication in the non-coding region of a HPV 6-subtype.J. Virol. 58, 963-966, 1986.
130. H. zur Hausen: Intracellular surveillance of persisting viral infections: Human genital cancer
resulting from failing cellular control of papillomavirus gene expression. Lancet 2, 489-491, 1986
131. A. Mincheva, L. Gissmann, and H. zur Hausen: Chromosomal integration sites of human
papillomavirus DNA in three cervical cancer cell lines mapped by in-situ hybridization. Medical Microbiol. Immunol. 176, 245-256, 1987
132. Klingel, A. Mincheva, T. Kahn, L. Gissmann, W. Dippold, T. Meyer, K.H. zum Büschenfelde, and H. zur Hausen: An amplification unit in human melanoma cells showing partial homology with sequences of human papillomavirus type 9 and Epstein-Barr virus nuclear antigen. Cancer Res. 47, 4485-4492, 1987
133. E.-M. de Villiers, D. Wagner, A. Schneider, H. Wesch, H. Micklaw, J. Wahrendorf, U. Papendick,and H. zur Hausen: Human papillomavirus infections in women withhout and with abnormal cervical cytology. Lancet 2, 703-706, 1987
134. E. Schwarz, A. Schneider-Gaedecke, and H. zur Hausen: Human papillomavirus type 18
transcription in cervical carcinoma cell lines and human cell hybrids. Cancer Cells: Papillomaviruses, Cold Spring Harbor Lab. Press, Vol. 5, 47-53, 1987
135. A. Stremlau, H.P. Zenner, L. Gissmann, and H. zur Hausen: Nachweis und Organisationsstruktur der DNS menschlicher Papillomviren beim Kehlkopf- und Hypopharynxcarcinom. Laryngol. Rhinol. Otol. 66, 311-315, 1987
136. M. Grimmel, E.-M. de Villiers, M. Pawlita, C. Neumann and H. zur Hausen: Characterization of a new human papillomavirus type (HPV 41) isolated from dissiminated warts and the detection of closely related sequences in some squamous cell carcinomas. Int. J. Cancer 41, 5-9, 1988
137. F. Rösl, M. Dürst, and H. zur Hausen: Selective suppression of human papillomavirus
transcription in non-tumorigenic cells by 5-azacytidine. EMBO J. 7, 1321-1328, 1988
138. H. zur Hausen: Papillomaviruses in human cancers. Mol. Carcinogenesis 1, 147-150, 1988
139. D. Greenspan, E.-M. de Villiers, J.S. Greenspan, Y.G. De Souza, and H. zur Hausen: Unusual
HPV types in oral warts in association with HIV infection. J. Oral Path. 17, 482-487, 1988
140. E.-M. de Villiers, A. Hirsch-Behnam, C. von Knebel Doeberitz, and H. zur Hausen: Two newly identified human papillomavirus types (HPV 40 and 57) isolated from mucosal lesions. Virology 171, 248-259, 1989
141. F. Rösl, E.-M. Westphal, and H. zur Hausen: Chromatin structure and transcriptional regulation of human papillomavirus type 18 DNA in HeLa cells. Mol. Carcinogenesis 2, 72-80, 1989
142. J. Schmitt, K. Mergener, L. Gissmann, J.R. Schlehofer, and H. zur Hausen: Amplification of
bovine papillomavirus DNA by N-methyl-N’-nitro-N-nitrosoguanidine, UV-irradiation, or infection by herpes simplex virus. Virology 172, 73-81, 1989
143. H. zur Hausen: Papillomaviruses in anogenital cancer: A model to understand the role of viruses in human cancers. Cancer Res. 49, 4677-4681, 1989
144. zur Hausen: Papillomaviruses as carcinomaviruses. In: Advances Viral Oncol. G. Klein, ed.,
Raven Press, New York, Vol. 8, 1-26, 1989
145. H. zur Hausen: Papillomaviruses in anogenital cancer – the dilemma of epidemiological
approaches. J. Nat. Cancer Inst. 81, 1680-1682, 1989
146. M. von Knebel Doeberitz and H. zur Hausen: Growth-regulting functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression. Cancer Res. 50, 3730-3736, 1990
147. F. Bosch, E. Schwarz, P. Boukamp, N.E. Fusenig, D. Bartsch, and H. zur Hausen: Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa-fibroblast hybrid cells. J. Virol. 64, 4743-4754, 1990
148. Dürst, F.X. Bosch, D. Glitz, A. Schneider, and H. zur Hausen: Inverse relationship between
human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV positive human cell lines. J. Virol. 65, 796-804, 1991
149. von Knebel Doeberitz, T. Bauknecht, D. Bartsch, and H. zur Hausen: Influence of
chromosomal integration on glucocorticoid regulated transcription of growth-stimulating
papillomavirus E6-E7 genes in cervical carcinoma cells. Proc. Nat. Acad. Sci. U.S. 88, 1411-1415,1991
150. zur Hausen: Papillomavirus-host cell interactions in the pathogenesis of anogenital cancer. In: Origins of Human Cancer II, J. Brugge, T. Curren, E. Harlow, and F. McCormick, eds. Cold Spring Harbor Lab. Press, pp. 685-705, 1991
151. F. Rösl, T. Achtstetter, K.-J. Hutter, T. Bauknecht, G. Futterman, and H. zur Hausen: Extinction of the HPV 18 upstream regulating region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO J. 10, 1337-1345, 1991
152. H. zur Hausen: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184,9-13, 1991
153. F. Hoppe-Seyler, K. Butz, and H. zur Hausen: Repression of human papillomavirus type 18
enhancer by the cellular transcription factor Oct-1. J. Virol. 65, 5613-5618, 1991
154. S. Reutter, H. Delius, T. Kahn, B. Hofmann, H. zur Hausen, and E. Schwarz: Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME 180. J. Virol. 65, 5564-5568, 1991
155. F.X. Bosch, M. Dürst, E. Schwarz, P. Boukamp, N.E. Fusenig, and H. zur Hausen. The early genes E6 and E7 of cancer associated papillomaviruses as targets of tumor suppression? Behring Inst. Mitt. 89, 108-121, 1991
156. E.-M. de Villiers, D. Wagner, A. Schneider, F. Munz, H. Micklaw, and H. zur Hausen: Human papillomavirus DNA in women without and with cytological abnormalities: Results of a five year follow-up study. Gynecol. Oncol. 44, 33-39, 1992
157. D. Bartsch, B. Boye, C. Baust, H. zur Hausen, and E. Schwarz: Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor b gene in nontumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 11, 2283-2291, 1992
158. T. Kahn, H. Friesl, N.G. Kopeland, D.J. Gilbert, N.A. Jenkins, L. Gissmann, J. Kramer, and H. zurHausen: Molecular cloning, analysis and chromosomal localization of a mouse genomic sequencerelated to the human papillomavirus type 18 E5 region. Mol. Carcinogenesis 6, 88-99, 1992
159. M. Dürst, D. Glitz, A. Schneider, and H. zur Hausen: Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189, 132-140, 1992
160. T. Bauknecht. P. Angel, H.-D. Royer, and H. zur Hausen: Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: Interaction with the transcriptional repressor YY1. EMBO J. 11, 4607-4617, 1992
161. M. von Knebel Doeberitz, C. Rittmüller, D. Glitz, H. zur Hausen, and M. Dürst: Inhibition of
tumorigenicity by cervical cancer cells in nude mice by HPV 18 E6-E7 antisense RNA. Int. J. Cancer 51, 831-834, 1992
162. B.C. Das, J,K, Sharma, V. Gopalkrishna, D.K. Das, V. Singh, L. Gissmann, H. zur Hausen, and U.K. Luthra. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J. Med.Virol. 36, 239-245, 1992.
163. F. Rösl, A. Arab, B. Klevenz, and H. zur Hausen: The effect of DNA methylation on gene
regulation of human papillomaviruses. J. Gen. Virol. 74, 791-801, 1993
164. H. zur Hausen: Molecular pathogenesis of cancer of the cervix and its causation by specific HPV types. Curr. Topics Microbiol. Immunol. 186, 131-156, 1994
165. Rösl, M. Lengert, J. Albrecht, K. Kleine, R. Zawatzky, B. Schraven, and H. zur Hausen:
Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) incervical carcinoma cells and derived hybrids. J. Virol. 68, 2142-2150, 1994
166. H. zur Hausen: Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 343, 955-957, 1994
167. T. Kahn, E. Turazza, R. Ojeda, A. Bercovich, a: Stremlau, P. Lichter, A. Poustka, S. Grinstein, and H. zur Hausen: Intergration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res. 54, 1305-1312, 1994
168. H. zur Hausen and E.-M. de Villiers: Human papillomaviruses. Ann. Rev. Microbiol. 48, 427-447,1994
169. Kitasato, H. Delius, H, zur Hausen, K. Sorger, F. Rösl, and E.-M. de Villiers: Sequence
rearrangements in the HPV 6 URR: Are these involved in malignant transition? J. Gen. Virol. 75,1157-1162, 1994
170. Shamanin, M. Glover, C. Rausch, C. Proby, I.M. Leigh, H. zur Hausen, and E.-M. de Villiers:Specific types of HPV found in benign proliferations and in carcinomas of the skin in
immunosuppressed patients. Cancer Res., 54,4610-4613, 1994
171. Delius, M.A. van Ranst, A.B. Jenson, H. zur Hausen, and J.P. Sundberg: Canine oral
papillomavirus genome sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frame. Virology 204, 447-452, 1994.
172. H. zur Hausen and F. Rösl: Pathogenesis of cancer of the cervix. Cold Spring Harbor Symp.
Quantit. Biol. 59, 623-628, 1994
173. Bauknecht, F. Jundt, I. Herr, T. Oehler, H. Delius, Y. Shi, P Angel, and H. zur Hausen: A
”switch region” determines cell type specific positive or negative action of YY1 on the activity of the HPV-18 promoter. J. Virol. 69, 1-12, 1995
174. M. Dürst, S. Seagon, S. Wanschura, H. zur Hausen, and J. Bullerdiek: Malignant progression of an HPV 16-immortalized human keratinocyte cell line (HPK IA) in vitro. Cancer Genetics & Cytogenetics, 85, 105-112, 1995
175. Kleine, K., König, G., Kreuzer, J., Komitowski, D., zur Hausen, H., and Rösl, F.: The role of the JE (MCP-1) gene encoding the monocyte chemoattractant protein-1 on the growth behaviour of HeLa cells and derived somatic cell hybrids in nude mice. Molecular Carcinogenesis, 14, 179-189, 1995
176. H. zur Hausen: Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix (Letter to the Editor). Int. J. Cancer, 63, 315-316, 1995.
177. F. Jundt, I. Herr, P. Angel, H. zur Hausen, and T. Bauknecht: Transcriptional control of human papillomavirus type 18 oncogene expression in different cell lines: role of transcription factor YY1. Virus Genes 11, 53-58, 1995.
178. H. zur Hausen: Roots and perspectives of contemporary papillomavirus research. J. Cancer Res. Clin. Oncol. 122, 3-13, 1996.
179. V. Shamanin, V., zur Hausen, H., Lavergne, D., Proby, C., Leigh, I.M., Neumann, C., Hamm, H., Goos, M., Haustein, U.-F., Jung, E.G., Plewig, G., Wolff, H., and de Villiers, E.-M. 1996. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J. Natl. Cancer Inst., 88, 802-811.
180. H. zur Hausen: Papillomavirus infections – a major cause of human cancers. Biochem. Biophys. Acta, Rev. on Cancer, 1288, F55-F78, 1996.
181. F. Rösl, B.C. Das, M. Lengert, K. Geletneky, and H. zur Hausen: Antioxidant-induced changes in AP-1 composition result in a selective suppression of human papillomavirus transcription. J. Virol. 71, 362-370, 1997.
182. T. Maehama, A. Patzelt, M. Lengert, K.-J. Hutter, K. Kanazawa, H. zur Hausen, and F. Rösl:
Selective down-regulation of the human papillomavirus transcription by 2-deoxyglucose. Int. J. Cancer, 76, 639-646, 1998
183. H. zur Hausen: Cervical cancer: Papillomaviruses and p53. News and Views, Nature, 393, 217,1998.
184. U. Soto, B.C. Das, M. Lengert, F. Finzer, H. zur Hausen, and F. Rösl: Conversion of HPV 18
positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-a mediatedrepression of viral transcription and modification of the AP-1 transcription complex. Oncogene, 18,3187-3198, 1999
185. zur Hausen, H.: Papillomaviruses in human cancers. Proc. Assoc. Am. Phys. 111,581-587, 1999.103. zur Hausen, H.: Papillomaviruses causing cancer: evasion from host cell control in early events incarcinogenesis. J. Nat. Cancer Inst. 92, 690-698, 2000.
186. Soto, U., Denk, C., Lengert, M., Finzer, P., Hutter, K.-J., zur Hausen, H., and Rösl, F. Genetic complementation to non-tumorigenicity in cervical carcinoma cells correlates with alterations in AP-1 composition. Int. J. Cancer, 86, 811-817, 2000.
187. Finzer, P., Soto, U., Delius, H., Patzelt, A., Coy, J.F., Poustka, A., zur Hausen, H., and Rösl, F. Differential transcriptional regulation of the moncyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: The role of chromatin structure and AP-1composition. Oncogene 19: 3235-3244, 2000.
188. Aguilar-Lemarroy, A., Kirchhoff, S., Whitaker, N., Gariglio, P., zur Hausen, H., Krammer, P.H., and Rösl, F. Differential sensitivity of human papillomavirus type 16 and 18-positive cervical carcinoma cells to CD95-mediated apoptosis. Int. J. Cancer 93: 823-831, 2001.
189. Finzer, P., Kuntzen, C., Soto, U., zur Hausen, H., and Rösl, F. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirusoncogene expression. Oncogene 20: 4768-4776, 2001.
190. Bosch, F.X.,Rohan, T., Schneider, A., Frazer, I., Pfister, H., Castellsagué, X., de Sanjosé, S.,
Moreno, V., Puig-Tintore, L.M., Smith, P.G., Muñoz, N., and zur Hausen, H. Papillomavirus researchupdate: highlights of the Barcelona HPV 2000 international papillomavirus conference. J. Clin.Pathol. 54: 164-175, 2001
191. zur Hausen, H. Cervical carcinoma and human papillomavirus: on the road to preventing a majorhuman cancer. Invited Editorial, J. Nat. Cancer Inst. 93: 252-253, 2001.
192. zur Hausen, H. Oncogenic DNA viruses. Oncogene 20: 7820-7823, 2001.
193. Bachmann, A., Hanke, B. Rawatzky, R., Soto, U., van Riggelen, J., zur Hausen, H., and Rösl, F. Disturbance of tumor necrosis factor alpha-mediated interferon beta signaling in cervical carcinoma cells. J. Virol., 76:280-291, 2002
194. Aguilar-Lemarroy, A., Gariglio, P., Whitaker, N., Eichhorst, S., zur Hausen, H., Krammer, P.H., and Rösl, F. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene, 21:165-175, 2002
195. zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nature
Rev. Cancer 2:342-350, 2002.
196. Cid-Arragui, A., Juárez, V. and zur Hausen, H. A synthetic E7 gene of human papillomavirus
type 16 that yields enhanced expression of the protein in mammalian cells and ist application to DNA immunization studies. J. Virol. 77: 4928-4937, 2003.
197. Helfrich, I., Chen, M., Schmidt, R., Fürstenberger, G., Kopp-Schneider, A., Trick, D., Gröne, H.-J, zur Hausen, H., and Rösl, F. Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis. J. Virol. 78:4797-4805, 2004
198. Villiers, E.-M., Fauquet, C., Broker, T.R., Bernard, H.-U., and zur Hausen, H. Classification
of papillomaviruses. Virology, 324: 17-27, 2004.
199. DeCastro Arce J., Soto U., Van Riggelen J., Schwarz E., zur Hausen H., Rösl F. Ectopic
expression of non-liganded RAR-{beta} abrogates AP-1 activity by selective degradation of c-Jun incervical carcinoma cells. J Biol Chem. 279: 45408-45416, 2004.
200. de Villiers, E.-M., Sandstrom, R.E., zur Hausen, H., and Buck, C.E. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res., 7: R1-11, 2005
201. Mossman, B.T., Klein, G. and zur Hausen, H. Modern criteria to determine the etiology of humancarcinogens. Semin. Cancer Biol. 14: 449-452, 2004.
202. van Riggelen, J., Buchwalter, G., Soto, U., DeCastro Arce, J., zur Hausen, H., Wasylyk, B., and Rösl, F. Loss of Net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells. J. Biol. Chem., 280: 3286-3294, 2004.
203. Báez-Astúa, A., García Garbi, N., Pasolli, H.A., Herraez-Hernandez, E., Juarez, V., zur Hausen, H., and Cid-Arregui, A. Low-does adenoviral vaccine encoding chimeric HBsAg-HPV16 E7 proteins induces E7-specific antibody and cytotoxic T cell responses. J. Virol. 79: 12897-12817, 2005.
204. H. zur Hausen. Perspectives of contemporary papillomavirus research. Vaccine, 24: Suppl 3:iiiiv,2006.
205. H. zur Hausen. Infections Causing Human Cancer. Wiley-VCH, Weinheim/New York (Publ.), pp. 1-517, 2006
Publications (Miscellaneous)
206. H. zur Hausen and A. Lange : Die Isolierung eines Fibroblasten-ähnlichen Zellstammes mit
heteroploider Transformation aus einer Primärkultur menschlicher Monozyten.
Naturwissenschaften 52, 95, 1964
207. H. zur Hausen, A. Lange, and J. Fröhlich : Cytolyse und Cyto-Agglutination permanenter
Mäusefibroblasten (L-strain) durch Humanserum. Naturwissenschaften 52, 558-559, 1964
208. A. Lange and H. zur Hausen : Über den Verlust der Neutralisierbarkeit von
Poliomyelitisviren im Verlauf ihrer Adsorption an Nierenepithelzellen von M. rhesus.
Zeitschr. f. Hygiene 150, 179-184, 1964
209. H. zur Hausen, H. Reinauer, J. Fröhlich, and A. Lange : Lipidspeicherung in permanenten
Mäusefibroblasten (L-strain, Earle) in Abhängigkeit von der Serumkonzentration.
Histochemische und quantitative Untersuchungen. Zeitschr. f. Naturforschung 19b,
1129-1134, 1964
210. H. zur Hausen, W. Mohrmann, and A. Lange: Eine Agartechnik zur Isolierung von
genetisch reinen Stämmen aus etablierten Gewebekulturzellen. Exp. Cell Res. 40, 138-139,
1965
211. zur Hausen and B. Störmer: Cytogenetische Untersuchungen an L-Zellen nach
Vaccinia-Virus-Infektion. Path. et Mikrobiol. 28, 962-973, 1965
212. H. zur Hausen and A. Lange: Isolierung eines permanenten Zellstammes aus
Affennierengewebe und sein Verhalten gegenüber Polioviren (Wildvirus und attenuiertes
Virus). Zentralbl. f. Bakteriol. I. Ref. 201, 336, 1966
213. H. zur Hausen, E. Lanz and B. Störmer: Chromosomale Aberrationen bei L-Zellen nach
Vaccinia-Virus-Infektion. Z. Med. Mikrobiol. Immunol. 152, 60-65, 1966
214. H. zur Hausen, E. Lanz and B. Störmer: Chromosomale Aberrationen nach latenter
Infektion eines klonierten L-Zellstammes mit Vaccinia-Virus. Z. Med. Mikrobiol. Immunol.
152, 66-72, 1966
215. H. zur Hausen, A. Lange and J. Fröhlich: Die Serumkonzentration als Auslesefaktor in
der Gewebekultur. Cytogenetische Untersuchungen an Mäusefibroblasten (strain L).
Cytologiy (Tokyo) 31, 339-348, 1966
216. H. zur Hausen : Chromosomal changes of similar nature in 7 established cell lines derived
from the peripheral blood of patients with leukemia. J. Natl. Cancer Inst. 38, 683-696, 1967
217. zur Hausen: Werner Henle 70 years. Med. Microbiol. Immunol. 168, 235-237, 1980
218. Neumann-Haefelin, A. Rethwilm, G. Bauer, F. Gudat, and H. zur Hausen:
Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells.
Med. Microbiol. Immunol. 172, 75-86, 1983
219. N. Yamamoto, Y. Hinuma, H. zur Hausen, J. Schneider, and G. Hunsmann: African green
monkeys are infected with adult T-cell leukemia virus or a closely related agent. Lancet 1,
240-241, 1983
220. R.C. Gallo, V.S. Klayanaraman, M.G. Sarngadharan, A. Sliski, E.C. Vonderheid, M.
Maeda, Y. Nakao, K. Yamada, Y. Ito, N. Gutensohn, S. Murphy, P.A. Bunn, jr., D. Catovsky,
M.F. Greaves, D.W. Blayney, W. Blattner, W.F.H. Jarrett, H. zur Hausen, M. Seligmann, R.C.
Brouet, B.F. Haynes, B.V. Jegasothy, E. Jaffe, J. Cossmann, S. Broder, R.I. Fisher, D.W.
Golde, and M. Robert-Guroff: Association of human type C retrovirus with a subset of adult
T-cell cancers. Cancer Res. 43, 3892-3899, 1983
221. U. Bantel-Schaal and H. zur Hausen: Characterization of the DNA of a defective human
parvovirus isolated from genital sites. Virology 134, 52-63, 1984
222. B. Georg-Fries, S. Biederlack, J. Wolf, and H. zur Hausen: Analysis of proteins, helper
dependence and seroepidemiology of a new human parvovirus. Virology 134, 64-71, 1984
223. R. Brossmer, B. Bohn, A. Sauer, and H. zur Hausen: A comparison of established human
lymphoma lines by flow cytometry: quantitation of ricinus communis agglutinine binding and
the effect of specific glycosidases. Eur. J. Cancer Clin. Oncol. 7, 825-831, 1985
224. H. zur Hausen: Wie gesund sind ”gesunde Bergschafe”? Münch. Med. Wochenschrift
129, 437-439, 1987
225. A.Ö. Yalkinoglu, R. Heilbronn, A. Bürkle, J.R. Schlehofer , and H. zur Hausen: DNA
amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res.
48, 3123-3129, 1988
226. M. von Knebel Doeberitz, S. Koch, H. Drzonek, and H. zur Hausen: Glucocorticoid
hormones reduce the expression of major histocompatibility class I antigens on human
epithelial cells. Europ. J. Immunol. 20, 35-40, 1990
227. S. Faisst, S. Barnitzke, J.R. Schlehofer, and H. zur Hausen: Persistence of parvovirus
H-1 in human B- and T-lymphoma cells. Virus Res. 16, 211-224, 1990
228. A.Ö. Yalkinoglu, J.R. Schlehofer, and H. zur Hausen: Inhibition of methyl-N’-nitro-Nnitrosoguanidine-induced methotrexate- and adriamycin-resistance in CHO cells by adenoassociatedvirus type 2. Int. J. Cancer 45, 1195-12o3, 1990
229. R. Heilbronn, A. Bürkle, S. Stephan, and H. zur Hausen: The adeno-associated rep-gene
suppresses herpes simplex virus induced DNA amplification. J. Virol. 64, 3012-3018, 1990
230. A. Bürkle, R. Heilbronn, and H. zur Hausen: Carcinogen-induced methotrexate
resistance and dihydrofolate reductase gene amplification: potentiation by inhibitors of poly
(ADP-ribose)polymerase. Cancer Res. 50, 5756-5760, 1990
231. C. Walz, J.R. Schlehofer, M. Flentje, and H. zur Hausen: Adeno-associated virus
sensitizes HeLa cell tumors to gamma rays. J. Virol. 66, 5651-5657, 1992
232. P. Klein-Bauernschmitt, H. zur Hausen, and J.R. Schlehofer: Induction of differentiationassociated changes in established human cells by infection with adeno-associated virus type 2. J. Virol. 66, 4191-4200, 1992
233. zur Hausen: Viruses in human tumors – personal reflections. Behring Inst. Mitt. 91,
21-27, 1992
234. J. Hermanns, P. Jansen-Dürr, J.A. Kleinschmidt, R. Schmidt, A. Schulze and H. zur
Hausen: Infection of primary cells by AAV2 results in a modulation of cell-cycle regulating
proteins. J. Virol. 71, 620-627, 1997.
235. U. Bantel-Schaal, H. Delius, R. Schmidt, and H. zur Hausen: Human adeno-associated
virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J.
Virol., 73, 939-94, 1999.
236. zur Hausen, H.: Proliferation-inducing viruses in non-permissive systems as possible
causes of human cancers. Lancet 2001; 357: 381-384.
237. de Villiers, E.-M., Schmidt, R., Delius, H., and zur Hausen, H. Heterogeneity of TT virus-like
sequences isolated from human tumour biopsies. J. Mol. Med. 2002; 80: 44-50.
238. Jelcic, I., Hotz-Wagenblatt, A., Hunzicker, A., zur Hausen, H., and de Villiers, E.-M. Isolation of multiple TTV genotypes from a spleen biopsy of a Hodgkin patient: Genome reorganization and diversity in the hypervariable region. J. Virol.,2004, 78: 7498-7507
239. Mossman, B.T., Klein, G. and zur Hausen, H. Modern criteria to determine the etiology of human carcinogens. Semin. Cancer Biol. 14: 449-452, 2004.
240. zur Hausen, H. and de Villiers, E.-M. A virus target cell conditioning model to explain some
epidemiological characteristics in childhood leukemias and lymphomas. Int J. Cancer, 115: 1-5, 2005.
241. Sospedra. M., Zhao, Y., zur Hausen, H., Muraro, P.A., Hamashin, P., de Villiers, E.-M., Pinilla, C., and Martin, R. Recognition of conserved amino acid motifs of common viruses and ist role in autoimmunity. PLOS Pathol. 1: 1-14, 2005.
242. H. zur Hausen. Streptococcus bovis (also S. infantarius): Causal or incidental involvement in
cancer of the colon? Editorial. Int. J. Cancer, 119: xi-xii, 2006.
243. Prusty, B.K., zur Hausen, H., Schmidt, R., Kimmel, R., and de Villiers, E.-M. Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignat
haematopoietic cells. February 2008, submitted.
Videos of Dr. Harald zur Hausen
Photos of Dr. Harald zur Hausen
